Sickle Cell Disease Global Clinical Trials Review, H1, 2016

  • ID: 3746075
  • Clinical Trials
  • Region: Global
  • 230 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Com
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
Sickle Cell Disease Global Clinical Trials Review, H1, 2016

Summary

Our clinical trial report, “Sickle Cell Disease Global Clinical Trials Review, H1, 2016" provides an overview of Sickle Cell Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Sickle Cell Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using Our proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Com
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
List of Tables

List of Figures

Report Guidance

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Five Countries Contributing to Clinical Trials in Middle East and Africa

Top Five Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Sickle Cell Disease Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About us

Contact Us

Disclaimer

Source

List of Tables

Sickle Cell Disease Therapeutics, Global, Clinical Trials by Region, 2016-

Sickle Cell Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016-

Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, North America, Top Countries, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016-

Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, G7 Countries (%), 2016-

Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016-

Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016-

Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, E7 Countries (%), 2016-

Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016-

Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016-

Sickle Cell Disease Therapeutics, Global, Clinical Trials by Phase, 2016-

Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2016-

Sickle Cell Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015

Sickle Cell Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016-

List of Figures

Sickle Cell Disease Therapeutics, Global, Clinical Trials by Region (%), 2016-

Sickle Cell Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016-

Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016-

Sickle Cell Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016-

Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, G7 Countries (%), 2016-

Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016-

Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016-

Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, E7 Countries (%), 2016-

Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016-

Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016-

Sickle Cell Disease Therapeutics, Global, Clinical Trials by Phase (%), 2016-

Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2016-

Sickle Cell Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015

Sickle Cell Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016-

Sickle Cell Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016-

Methodology
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Pfizer Inc.
Eli Lilly and Company
Novartis AG
Prolong Pharmaceuticals, LLC
Global Blood Therapeutics, Inc.
HemaQuest Pharmaceuticals, Inc.
Gilead Sciences, Inc.
Daiichi Sankyo Company, Limited
Children's Healthcare of Atlanta Inc.
Bristol-Myers Squibb Com
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll